Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
about
DNA Damage and Pulmonary HypertensionCellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertensionActivation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxiaCirculating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling.The microRNA-130/301 family controls vasoconstriction in pulmonary hypertensionEffect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice.Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.HLA-B35 upregulates endothelin-1 and downregulates endothelial nitric oxide synthase via endoplasmic reticulum stress response in endothelial cells.The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives.Epigenetic regulation of pulmonary arterial hypertension.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension.Hyperactive TGF-β Signaling in Smooth Muscle Cells Exposed to HIV-protein(s) and Cocaine: Role in Pulmonary Vasculopathy.Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.Downregulation of bone morphogenetic protein receptor axis during HIV-1 and cocaine-mediated pulmonary smooth muscle hyperplasia: implications for HIV-related pulmonary arterial hypertension.Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinflammatory factors.A novel murine model of severe pulmonary arterial hypertension.A novel coculture model of HUVECs and HUASMCs by hyaluronic acid micropattern on titanium surface.Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series).Editorial Focus on #H-00540-2017R1: When higher cholesterol is better: membrane cholesterol loss and endothelial calcium signaling.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.An integrative view on the carotid artery alterations in metabolic syndrome.AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.Macrophage-derived extracellular vesicles mediates smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV-infection and substance abuse.Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells.Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling.Hypoxia induces endothelial‑mesenchymal transition in pulmonary vascular remodeling.Hypoxic-induction of arginase II requires EGF-mediated EGFR activation in human pulmonary microvascular endothelial cells.Heterocellularity and Cellular Cross-Talk in the Cardiovascular System
P2860
Q27005594-BF7BAF59-63A8-4EA0-B121-C59AE2434943Q33806253-7DABE5CE-A315-47CA-AA76-0F6350F9FA16Q34208940-7A72A850-FAF5-42A3-ADEC-CFE9BFBAF4E6Q34769618-9C8CEC3B-AB5A-42E9-B46F-7CAA45538358Q34981727-98DD7455-2219-498C-A04A-B13642C1C868Q35002833-BA6A494B-7AAA-47F7-A337-B9E22DAC025CQ35132178-5E71BF94-82F3-4C07-8C19-DA45C472CF19Q35184983-28B912D1-65AD-437E-97F8-8AAC7C961454Q37100777-6D3DA1CE-16B7-4D65-AA58-7F5A13B87890Q37112033-09C2E94C-F0BE-4CC4-BF25-782E3A43AF0EQ37332304-52EF858B-9497-4FF0-8523-755C770FC495Q37849077-D3044FE5-4286-42BC-807C-CF6A8C0A4AA2Q37890242-77C0BF37-1A4B-40B5-BAA8-D6097806A1A7Q38112038-35F2BA9F-E2AD-4132-AE1E-2ED71FEB8CC2Q39132107-8693AA38-F1D8-45EB-90B7-7ECB590FE7FAQ39405856-1CB3B43A-EED6-4FCB-8706-F9E0BDA6B282Q40065596-55CE82B0-6AF7-4639-9E94-47FEAE765A13Q41895695-24E2B49F-9578-4AFA-B2C6-B4891C882766Q42134956-8D991923-E609-4D47-8172-5318F0D041D8Q42727047-8255755A-C060-4789-9253-C938465D5CEFQ43409467-877272DD-FAD8-4C4C-A9DF-B06183680DFBQ44889182-D0C33ECA-C28E-478D-9AFC-185CFD7BBBCFQ48338437-278D343D-416F-4EAF-A1F3-BFEFED45F87BQ49917707-1CCB3723-328C-4019-BBD4-A48F1562E6E1Q50124360-C5F504B4-72C1-4D7A-A763-23FD2BBECF42Q51367456-6B3C8173-8558-4AB6-A908-93E5D20515EAQ52430975-07047D6F-1C89-4418-9A49-406ABE5F4F3EQ52718334-03842360-0920-4949-A0EC-855D50FCFF8FQ53732001-B616576A-A78D-4B36-8C8D-2AA38E7CC413Q54476060-2C3690D7-5311-487C-BFCB-FBCE7A5E3A9CQ54603077-E887EFE6-4984-4810-884D-9786F6EC681FQ55191278-B1F62930-6186-43EE-87BA-FC14D36EEC63Q55545711-5FA93027-FD70-41AE-B09D-1C0B041BB61FQ59133004-6D5B8B46-250C-444A-8F96-F757D29EA602
P2860
Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@en
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@nl
type
label
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@en
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@nl
prefLabel
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@en
Endothelial cell dysfunction a ...... lmonary arterial hypertension.
@nl
P50
P1476
Endothelial cell dysfunction a ...... ulmonary arterial hypertension
@en
P2093
Saadia Eddahibi
Serge Adnot
P304
P356
10.1016/J.VPH.2008.06.003
P577
2008-06-20T00:00:00Z